Skip to main content
SleepCited

Ashwagandha لـ الأرق

A الأدلة تُظهر تجارب سريرية كبيرة متعددة باستمرار فوائد ملحوظة.

بناءً على 30 دراسة (4 meta-analyses, 5 RCTs) بمشاركة 1,810 مشاركًا إجمالاً. 29/30 دراسة تُظهر تأثيرات إيجابية.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003Dashwagandha\u0026condition\u003Dinsomnia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

الخلاصة

Ashwagandha is one of the most well-researched herbal supplements for insomnia, with strong and consistent evidence that it may support better sleep quality.

  • 29 out of 30 studies show positive effects, including 5 RCTs and 4 meta-analyses
  • Grade A evidence — the highest level of support among sleep supplements
  • Works through multiple pathways including GABA receptors, histamine modulation, and stress reduction
  • Both healthy adults and people with insomnia have shown improvements in clinical trials

Key Study Findings

Review
The Clinical Implications of Ashwagandha (Withania somnifera L.) with a Special Reference to Side Effects-A …
Dose: None مقابل: None Outcome: None التأثير: None None

المجتمع المدروس: narrative review of ashwagandha clinical trials and basic research (1994-present)

Review
Integrative sleep management: from molecular pathways to conventional and herbal treatments.
Dose: None مقابل: Placebo التأثير: None None
preclinical animal/in vitro study
Ashwagandha (Withania somnifera (L.) dunal) root extract containing withanolide a alleviates depression-like behavior in mice …
Dose: 60 and 100 mg/kg (mice); 100 and 200 µg/mL (HT-22 cells); withanolide A 1.56 and 3.12 µg/mL مقابل: Placebo التأثير: None None
RCT n=90 12 weeks Double-blind
A New Ashwagandha Formulation (Zenroot™) Alleviates Stress and Anxiety Symptoms While Improving Mood and Sleep …
Dose: 125 mg Zenroot (Ashwagandha with 1.5% total withanolides) daily مقابل: Placebo التأثير: None < 0.05
Meta-analysis n=713 8 weeks Double-blind
The effect of Withania somnifera (Ashwagandha) on mental health symptoms in individuals with mental disorders: …
Dose: 600 mg/day (median) مقابل: Placebo التأثير: SMD=-1.13 (anxiety, outlier-corrected); SMD=-1.28 (depression); SMD=-0.95 (stress); SMD=-1.35 (sleep None
Case Report n=1
Unmasking Potential Withdrawal Effects of Ashwagandha: A Case Report and Review.
Dose: Ashwagandha extract 600 mg/day (prior to discontinuation) مقابل: Placebo التأثير: None None

Key Statistics

31

الدراسات

1810

المشاركون

Positive

A

التقييم

Referenced Papers

Naunyn-Schmiedeberg's archives of … 2025 4 اقتباسات
International journal of … 2023 43 اقتباسات
Child and adolescent … 2023 5 اقتباسات
Pharmacological research 2022 51 اقتباسات
Journal of ethnopharmacology 2020 85 اقتباسات
Phytotherapy research : … 2018 95 اقتباسات
Biological & pharmaceutical … 2014 110 اقتباسات

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

الجرعات الشائعة

sleep:
300-600 mg KSM-66 or Sensoril, before bed

الحد الأعلى: Not established; studied up to 1,200 mg/day

الجرعات المدروسة في الأبحاث

الجرعة المدة التأثير ن
None -- Positive --
None -- Positive --
60 and 100 mg/kg (mice); 100 and 200 µg/mL (HT-22 cells); withanolide A 1.56 and 3.12 µg/mL -- Positive --
125 mg Zenroot (Ashwagandha with 1.5% total withanolides) daily 12 weeks Positive 90
600 mg/day (median) 8 weeks Positive 713
Ashwagandha extract 600 mg/day (prior to discontinuation) -- Negative 1
ashwagandha 250 mg/day, ashwagandha 250 mg + tryptophan 175 mg/day, or ashwagandha 600 mg/day (250 m 13 weeks Positive 52
varies across included RCTs -- Positive 254

أفضل وقت للتناول: 1-2 hours before bed

Safety & Side Effects

الآثار الجانبية المُبلّغ عنها

  • Drowsiness
  • GI upset
  • Diarrhea
  • Headache

التفاعلات المعروفة

  • Thyroid medications — ashwagandha may increase thyroid hormone levels
  • Immunosuppressants — ashwagandha may stimulate immune activity
  • Sedatives — potential additive drowsiness
  • Blood sugar medications — may lower blood glucose

الحد الأقصى المسموح به: Not established; studied up to 1,200 mg/day

استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.

Frequently Asked Questions

Does Ashwagandha help with الأرق?
Based on 31 studies with 1,810 participants, there is strong evidence from multiple clinical trials that Ashwagandha may support الأرق management. Our evidence grade is A (Strong Evidence).
How much Ashwagandha should I take for الأرق?
Studies have used various dosages. A commonly studied range is 300-600 mg KSM-66 or Sensoril, before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Ashwagandha?
Reported side effects may include Drowsiness, GI upset, Diarrhea, Headache. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Ashwagandha and الأرق?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 31 peer-reviewed studies with 1,810 total participants. The overall direction of effect is positive.

References

  1. [1] Kaj Winther. Nutrients. 2026. The Clinical Implications of Ashwagandha (Withania somnifera L.) with a Special Reference to Side Effects-A Review. doi:10.3390/nu18050871 PubMed
  2. [2] Maria-Nina Căuș et al.. Pharmaceuticals (Basel). 2026. Efficacy and Safety of Herbal Supplements with Anxiolytic, Antidepressant, and Sedative Action: A Review of Clinical Data and Toxicological Risks. doi:10.3390/ph19030399 PubMed
  3. [3] Hyeongyeong Kim et al.. J Ethnopharmacol. 2025. Ashwagandha (Withania somnifera (L.) dunal) root extract containing withanolide a alleviates depression-like behavior in mice by enhancing the brain-derived neurotrophic … doi:10.1016/j.jep.2024.119224 PubMed
  4. [4] Yasmina M Ebrahim et al.. Naunyn Schmiedebergs Arch Pharmacol. 2025. Integrative sleep management: from molecular pathways to conventional and herbal treatments. doi:10.1007/s00210-025-04183-y PubMed
  5. [5] Mattia Marchi et al.. BJPsych Open. 2025. The effect of Withania somnifera (Ashwagandha) on mental health symptoms in individuals with mental disorders: systematic review and meta-analysis. doi:10.1192/bjo.2025.10885 PubMed
  6. [6] Andrew Holzman et al.. Cureus. 2025. Unmasking Potential Withdrawal Effects of Ashwagandha: A Case Report and Review. doi:10.7759/cureus.83577 PubMed
  7. [7] Manasvi Mahadevan et al.. Adv Ther. 2025. A New Ashwagandha Formulation (Zenroot™) Alleviates Stress and Anxiety Symptoms While Improving Mood and Sleep Quality: A Randomized, Double-Blind, Placebo-Controlled … doi:10.1007/s12325-025-03327-z PubMed
  8. [8] Xiaoxing Liu et al.. J Ethnopharmacol. 2024. Withania somnifera root extract inhibits MGO-induced skin fibroblast cells dysfunction via ECM-integrin interaction. doi:10.1016/j.jep.2023.117699 PubMed
  9. [9] Kaneez Fatima et al.. Hum Psychopharmacol. 2024. Safety and efficacy of Withania somnifera for anxiety and insomnia: Systematic review and meta-analysis. doi:10.1002/hup.2911 PubMed
  10. [10] Alex B Speers et al.. Nutrients. 2024. Quantifying Withanolides in Plasma: Pharmacokinetic Studies and Analytical Methods. doi:10.3390/nu16223836 PubMed
  11. [11] Silvia Pérez-Piñero et al.. Clocks Sleep. 2024. Effectiveness of Enriched Milk with Ashwagandha Extract and Tryptophan for Improving Subjective Sleep Quality in Adults with Sleep Problems: A … doi:10.3390/clockssleep6030028 PubMed
  12. [12] Michał Wiciński et al.. Int J Mol Sci. 2023. Can Ashwagandha Benefit the Endocrine System?-A Review. doi:10.3390/ijms242216513 PubMed
  13. [13] Chun Woong Park et al.. J Food Drug Anal. 2023. Sleep-promoting activity of amylase-treated Ashwagandha (Withania somnifera L. Dunal) root extract via GABA receptors. doi:10.38212/2224-6614.3456 PubMed
  14. [14] Swapna N Deshpande et al.. Child Adolesc Psychiatr Clin N Am. 2023. Complementary and Integrative Approaches to Sleep Disorders in Children. doi:10.1016/j.chc.2022.08.008 PubMed
  15. [15] Wenting Zhang et al.. Pharmacol Res. 2022. Medicinal herbs for the treatment of anxiety: A systematic review and network meta-analysis. doi:10.1016/j.phrs.2022.106204 PubMed
  16. [16] Sonu Pahal et al.. J Biomol Struct Dyn. 2022. Network pharmacological evaluation of Withania somnifera bioactive phytochemicals for identifying novel potential inhibitors against neurodegenerative disorder. doi:10.1080/07391102.2021.1951355 PubMed
  17. [17] Sindgi Vasudeva Murthy et al.. Prev Nutr Food Sci. 2022. Hydroalcoholic Extract of Ashwagandha Improves Sleep by Modulating GABA/Histamine Receptors and EEG Slow-Wave Pattern in In Vitro - In Vivo … doi:10.3746/pnf.2022.27.1.108 PubMed
  18. [18] Alex B Speers et al.. Curr Neuropharmacol. 2021. Effects of Withania somnifera (Ashwagandha) on Stress and the Stress- Related Neuropsychiatric Disorders Anxiety, Depression, and Insomnia. doi:10.2174/1570159X19666210712151556 PubMed
  19. [19] Heba M A Khalil et al.. J Ethnopharmacol. 2021. Ashwagandha (Withania somnifera) root extract attenuates hepatic and cognitive deficits in thioacetamide-induced rat model of hepatic encephalopathy via induction of … doi:10.1016/j.jep.2021.114141 PubMed
  20. [20] Kae Ling Cheah et al.. PLoS One. 2021. Effect of Ashwagandha (Withania somnifera) extract on sleep: A systematic review and meta-analysis. doi:10.1371/journal.pone.0257843 PubMed
  21. [21] Deepak Langade et al.. J Ethnopharmacol. 2021. Clinical evaluation of the pharmacological impact of ashwagandha root extract on sleep in healthy volunteers and insomnia patients: A double-blind, … doi:10.1016/j.jep.2020.113276 PubMed
  22. [22] Silvia Borrás et al.. Planta Med. 2021. Medicinal Plants for Insomnia Related to Anxiety: An Updated Review. doi:10.1055/a-1510-9826 PubMed
  23. [23] Sriram Gopal et al.. J Obstet Gynaecol Res. 2021. Effect of an ashwagandha (Withania Somnifera) root extract on climacteric symptoms in women during perimenopause: A randomized, double-blind, placebo-controlled study. doi:10.1111/jog.15030 PubMed
  24. [24] Priya Pathak et al.. J Ethnopharmacol. 2021. Standardized root extract of Withania somnifera and Withanolide A exert moderate vasorelaxant effect in the rat aortic rings by enhancing … doi:10.1016/j.jep.2021.114296 PubMed
  25. [25] Nawab John Dar et al.. J Ethnopharmacol. 2020. Neurodegenerative diseases and Withania somnifera (L.): An update. doi:10.1016/j.jep.2020.112769 PubMed
  26. [26] Upadhyay Atul et al.. Ayu. 2020. Efficacy of Brimhana Nasya and Ashwagandha (Withania somnifera (L.) Dunal) root powder in primary insomnia in elderly male: A randomized … doi:10.4103/ayu.AYU_177_19 PubMed
  27. [27] Deepak Langade et al.. Cureus. 2019. Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Insomnia and Anxiety: A Double-blind, Randomized, Placebo-controlled Study. doi:10.7759/cureus.5797 PubMed
  28. [28] Karen Savage et al.. Phytother Res. 2018. GABA-modulating phytomedicines for anxiety: A systematic review of preclinical and clinical evidence. doi:10.1002/ptr.5940 PubMed
  29. [29] Abhijit Deshpande et al.. Medicine (Baltimore). 2018. Study protocol and rationale for a prospective, randomized, double-blind, placebo-controlled study to evaluate the effects of Ashwagandha (Withania somnifera) extract … doi:10.1097/MD.0000000000011299 PubMed
  30. [30] Mahesh K Kaushik et al.. PLoS One. 2017. Triethylene glycol, an active component of Ashwagandha (Withania somnifera) leaves, is responsible for sleep induction. doi:10.1371/journal.pone.0172508 PubMed
  31. [31] Manuel Candelario et al.. J Ethnopharmacol. 2015. Direct evidence for GABAergic activity of Withania somnifera on mammalian ionotropic GABAA and GABAρ receptors. doi:10.1016/j.jep.2015.05.058 PubMed
  32. [32] Tomoharu Kuboyama et al.. Biol Pharm Bull. 2014. Effects of Ashwagandha (roots of Withania somnifera) on neurodegenerative diseases. doi:10.1248/bpb.b14-00022 PubMed

إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.